Hospital acquired pneumonia risk factors in children with Acute Lymphoblastic Leukemia on chemotherapy

Anitha Marllyin Mairuhu1, Mia Ratwita Andarsini1, Retno Asih Setyoningrum1

  • 1Department of Child Health, Universitas Airlangga, Faculty of Medicine Dr. Soetomo General Academic Hospital, Surabaya Indonesia.

Heliyon
|June 25, 2021
PubMed

Insights

Hospital-Acquired Pneumonia (HAP) is a significant risk for children with Acute Lymphoblastic Leukemia (ALL) undergoing chemotherapy. Risk stratification, chemotherapy phase, and neutropenia are key factors influencing HAP incidence in this vulnerable population.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Hematology

Background:

  • Infection is a leading cause of morbidity and mortality in pediatric Acute Lymphoblastic Leukemia (ALL) patients on chemotherapy.
  • Hospital-Acquired Pneumonia (HAP) represents a significant threat requiring early intervention for at-risk children with ALL.

Purpose of the Study:

  • To identify and analyze risk factors associated with the incidence of Hospital-Acquired Pneumonia (HAP) in pediatric patients undergoing chemotherapy for Acute Lymphoblastic Leukemia (ALL).

Main Methods:

  • An observational case-control study was conducted involving pediatric ALL patients on chemotherapy between 2016 and 2018.
  • Cases were patients with HAP, and controls were patients without HAP.
  • Nine potential risk factors were analyzed using bivariate and multivariate statistical methods, including logistic regression.

Main Results:

  • The study included 120 children.
  • Significant risk factors for HAP in pediatric ALL patients on chemotherapy were identified as risk stratification (p = 0.009), chemotherapy phase (p < 0.001), and neutropenia (p < 0.001).
  • Age, gender, nutritional status, length of stay, anemia, and thrombocytopenia were not found to be significant risk factors.

Conclusions:

  • Risk stratification, chemotherapy phase, and neutropenia are significantly associated with the incidence of Hospital-Acquired Pneumonia (HAP) in children with Acute Lymphoblastic Leukemia (ALL) undergoing chemotherapy.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
447
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
546
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.8K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55